Class Action

DayQuil Cough Medicine


Case Name (Date)

Diesel et al. v. The Procter & Gamble Co.
22-cv-892, E.D. Mo.
(July 2022)

Meza et al. v. The Procter & Gamble Co.
23-cv-241, S.D. Ohio
(Jan. 2023)


Product/Service

DayQuil cough medicine


Allegations

Falsely marketing medicine as “non-drowsy” when an ingredient (dextromethorphan hydrobromide, or DXM) causes drowsiness


Status

Pending



Class-Action Tracker

DayQuil Super C

Class Action

DayQuil Super C

Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…


The Latest

Filters


Show More